勛圖厙桴

Latest

Latest biomarker News

  • Latest biomarker news stories and updates. What is happening today? All recent biomarker news and developments. Live coverage and timeline of biomarker. All you need to know about biomarker.
AI analysis of immune cells can predict breast cancer prognosis
World’s First Patent Acquired for Animal Supplement “Pinfenon” (S) (R)
Mitochondrial DNA Levels Impact Tumor Size
New findings could help offer future treatments for unexplained infertility
Biomarker Can Help Healthcare Assess Severity Of Covid
Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
Our 2023 Annual Report
New study sheds light on Alzheimer’s Disease progression
Cell-Free DNA, ‘Spider-Man’ Neutrophils, and Sepsis in Foals
New study: High fat diet fuels production of key biomarker for metabolic diseases
Alterity Therapeutics reports positive interim data from Multiple System Atrophy trial
Actinogen Medical says positive Xanamem phase 2a biomarker trial published in key Journal
C3i Center Inc is First CDMO in Canada to Receive Approval for a Drug Establishment License to Commercially Produce Cell Therapy Drug Products
Prevention towards unwanted side effects of cancer treatment in children
瞿1.5m gift from Simon Sadler enables provision of new bursary for care leavers
The HILPAprotein: A potential biomarker for new treatment options in aggressive kidney cancer
The HILPDA Protein: A Potential Biomarker for New Treatment Options in aggressive Kidney Cancer
‘Cancer-cooling’ protein puts bowel cancer on ice
ChemPartner Unveils Highly Anticipated Biology Database
Chronic migraine research finds genetic mechanism to lower migraine frequency
Alterity Therapeutics raises $4.8 million in new placement
Enhertu demonstrated clinically meaningful survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Detecting Parkinson’s disease decades before symptoms appear
AstraZeneca research reveals unique associations between rare changes in genes and plasma proteins that could improve drug discovery with data from over…
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Actinogen CMO presents academic poster to Alzheimer’s Association International Conference
First patient dosed in study of TLX250-CDx exploring indication expansion
Mater Researchers shine fluorescent light on men’s health outcomes
Enhertu demonstrated clinically meaningful and durable responses in patients across multiple HER2-expressing advanced solid tumours
Pharmaxis reports positive results from trial of PXS6302
A novel biomarker and potential improved therapy for multiple sclerosis and related neurodegenerative disorders
Acid Glia in REM sleep: Stronger Acid Response in Epileptic Mice
Salt, calcium and vitamin D – do you get enough, or too much?
Capivasertib plus Faslodex reduced risk of disease progression or death by 40% versus Faslodex
Severe Covid risk elevated by high triglyceride level
AstraZeneca aims to redefine breast cancer care with new data across treatment spectrum at SABCS 2022
Researchers may have found new biomarker for acute Covid
TheraP biomarker analysis
NATURE publishes data on DUNP19 receptors role in cancer growth
Imugene doses first patient in nextHERIZON Phase 2 clinical trial
Covid disruptions take heavy toll on those with type 2 diabetes
Training Virtually Can Reduce Psychosocial Stress and Anxiety
When it comes to ADHD and ASD, the eyes could reveal all
Fast Five with Dr David Chieng
INOViQ announces manufacturing agreement with MP Biomedicals
Enhertu granted Priority Review in US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
Fast Five with Dr Alin Rai
Easy test can see if breeding bulls have right stuff

穢 2024 - 勛圖厙桴